EQ/T.Rowe Price Health Sciences Portfolio

EQ/T.Rowe Price Health Sciences Portfolio reported 188 holdings worth US$177M as of Jun 30, 2026 (Form N-PORT)

As of Jun 30, 2026 · Filed Aug 25, 2026

EQ/T.Rowe Price Health Sciences Portfolio reported 188 holdings worth US$177M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. Filed Aug 25, 2026 (Form N-PORT).

Holdings
188
Value as reported
US$177M

The filing in full

CompanySharesValue as reported% of portfolio
Eli Lilly And Company21,120US$25.3M14.3%
Johnson & Johnson44,072US$11.2M6.3%
Unitedhealth Group Incorporated25,398US$10.6M6.0%
Abbvie Inc.37,236US$9.37M5.3%
Merck & Company, Inc.58,349US$7.5M4.2%
Gilead Sciences, Inc.41,362US$5.23M3.0%
Thermo Fisher Scientific Inc9,404US$4.71M2.7%
Vertex Pharmaceuticals Incorporated8,487US$4.22M2.4%
Bristol-myers Squibb Company68,555US$3.95M2.2%
Abbott Laboratories39,200US$3.56M2.0%
Intuitive Surgical, Inc.8,815US$3.51M2.0%
Amgen Inc.9,359US$3.39M1.9%
Stryker Corporation10,613US$3.34M1.9%
Elevance Health, Inc.7,394US$2.86M1.6%
Danaher Corporation13,953US$2.66M1.5%
Natera, Inc.9,745US$2.65M1.5%
Guardant Health, Inc.15,290US$2.29M1.3%
Cardinal Health, Inc.8,206US$1.95M1.1%
Royalty Pharma Plc32,273US$1.81M1.0%
Tenet Healthcare Corporation9,417US$1.76M1.00%
Cvs Health Corporation16,818US$1.74M0.99%
Kymera Therapeutics, Inc.14,490US$1.66M0.94%
Protagonist Therapeutics, Inc.13,021US$1.6M0.90%
Moderna, Inc.22,200US$1.55M0.88%
Brightspring Health Services, Inc.22,264US$1.55M0.88%
Revolution Medicines, Inc.7,895US$1.48M0.84%
Roivant Sciences Ltd.37,885US$1.34M0.76%
Alnylam Pharmaceuticals, Inc.4,286US$1.29M0.73%
Viatris Inc.76,300US$1.21M0.69%
Charles River Laboratories International, Inc.5,100US$1.16M0.65%
Argenx Se1,204US$1.12M0.63%
Edwards Lifesciences Corporation12,186US$1.1M0.62%
Centene Corporation16,955US$1.09M0.62%
Spyre Therapeutics, Inc.11,317US$1M0.57%
Definium Therapeutics, Inc.20,192US$950K0.54%
Insmed Incorporated8,728US$931K0.53%
Chugai Pharmaceutical Co., Ltd.19,400US$898K0.51%
Twist Bioscience Corporation8,700US$895K0.51%
Astrazeneca Plc4,558US$864K0.49%
Boston Scientific Corporation19,774US$844K0.48%
United Therapeutics Corporation1,521US$824K0.47%
Krystal Biotech, Inc.2,207US$820K0.46%
Medtronic Plc.10,400US$814K0.46%
Erasca, Inc.40,500US$742K0.42%
Mirum Pharmaceuticals, Inc.6,210US$727K0.41%
Billiontoone, Inc.5,958US$715K0.40%
Praxis Precision Medicines, Inc.2,107US$705K0.40%
Beone Medicines Ltd. Class A2,531US$699K0.40%
Tango Therapeutics, Inc.21,992US$687K0.39%
Ascendis Pharma A/s2,570US$685K0.39%
Monte Rosa Therapeutics, Inc.28,115US$680K0.39%
Scholar Rock Holding Corporation12,192US$671K0.38%
Medpace Holdings, Inc.1,265US$670K0.38%
Humana Inc.1,680US$667K0.38%
Dianthus Therapeutics, Inc.6,843US$667K0.38%
Oruka Therapeutics, Inc.6,967US$663K0.38%
Kodiak Sciences Inc15,917US$620K0.35%
Axsome Therapeutics, Inc.2,379US$582K0.33%
Summit Therapeutics Inc.39,654US$578K0.33%
Novo Nordisk A/s Class B11,984US$567K0.32%
Cytokinetics, Incorporated6,427US$548K0.31%
Regeneron Pharmaceuticals, Inc.878US$547K0.31%
Mbx Biosciences, Inc.9,865US$545K0.31%
Ionis Pharmaceuticals, Inc.6,852US$543K0.31%
Cg Oncology, Inc.7,622US$542K0.31%
Vera Therapeutics, Inc.12,402US$532K0.30%
Relay Therapeutics, Inc.27,509US$515K0.29%
Kailera Therapeutics, Inc.23,307US$513K0.29%
Enliven Therapeutics, Inc.10,047US$510K0.29%
Nurix Therapeutics, Inc.20,883US$507K0.29%
Agilent Technologies, Inc.3,800US$505K0.29%
Crinetics Pharmaceuticals, Inc.13,341US$499K0.28%
Newamsterdam Pharma Company N.v.14,300US$485K0.27%
Madrigal Pharmaceuticals, Inc.900US$483K0.27%
Waters Corporation1,280US$480K0.27%
Rhythm Pharmaceuticals, Inc.4,253US$472K0.27%
West Pharmaceutical Services, Inc.1,300US$467K0.26%
Liquidia Corporation5,738US$457K0.26%
Beam Therapeutics Inc.13,174US$452K0.26%
Bridgebio Pharma, Inc.5,971US$445K0.25%
Ideaya Biosciences, Inc.11,415US$425K0.24%
Teva Pharmaceutical Industries Limited12,500US$424K0.24%
Viridian Therapeutics, Inc.22,670US$416K0.24%
Alkermes Plc7,900US$414K0.23%
Immunome, Inc.19,300US$409K0.23%
Alignment Healthcare, Inc.16,656US$397K0.22%
Vaxcyte, Inc.6,552US$381K0.22%
Rapport Therapeutics, Inc.8,604US$359K0.20%
Palvella Therapeutics, Inc.2,275US$348K0.20%
Climb Bio, Inc.25,624US$334K0.19%
Icon Plc1,900US$330K0.19%
Seaport Therapeutics, Inc.14,818US$322K0.18%
Bicara Therapeutics Inc.9,747US$289K0.16%
Sonova Holding Ag1,214US$288K0.16%
Oric Pharmaceuticals, Inc.26,425US$286K0.16%
Celldex Therapeutics, Inc.7,404US$276K0.16%
Moonlake Immunotherapeutics14,014US$273K0.15%
Cencora, Inc.953US$270K0.15%
Alumis Inc.9,325US$262K0.15%
Apogee Therapeutics, Inc.1,936US$257K0.15%

Every holding of EQ/T.Rowe Price Health Sciences Portfolio

Source

View original at SEC

Related